Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Carcinoma

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Carcinoma, Bronchogenic

Bronchial Neoplasms

All Drugs and Chemicals

Anti-Infective Agents

Fluorodeoxyglucose F18

Deoxyglucose

Irradiation of all tumor manifestations detectable by CT and/or positron emission tomography using fluoro-deoxy-glucose including a part of eventual atelectasis and the whole affected lymph node stations by 60 - 74 Gy/2Gy) irradiation of elective lymph node stations up to 50 Gy/2 Gy

Irradiation of all tumor manifestations detectable by positron emission tomography using fluoro-deoxy-glucose including the whole affected lymph node stations by 60 - 74 Gy/2Gy

Restriction of target volumes to areas positive in positron emission tomography using fluoro-deoxy-glucose

restriction of radiotherapy to FDG-PET positive areas only

U. Nestle, Prof.

A. L. Grosu, Prof.

T. Schimek-Jasch, MD

S. Adebahr, MD

Ursula Nestle, Prof.

A.-L. Grosu, Prof.

Simultaneous radio-chemotherapy in advanced non-small cell lung cancer. The study focusses on a randomised comparison of conventional radiotherapy planning with irradiation of macroscopic tumor and lymph nodes together with prophylactic target volumes vs. irradiation only of FDG-positive lesions.

Primary endpoint is the local disease control in the chest.

Simultaneous radio-chemotherapy in advanced non-small cell lung cancer. The study focusses on a randomised comparison of conventional radiotherapy planning with irradiation of macroscopic tumor and lymph nodes together with prophylactic target volumes vs. irradiation only of FDG-positive lesions.

Primary endpoint is the local disease control in the chest

Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC

Optimisation of Radiotherapy-Planning in Patients With Inoperable Locally Advanced Non-Small-Cell Lung Cancer by FDG-PET

Time from randomization to first evidence of local progression or last follow up

Time from randomization to death or last follow up

Time from randomization to progression or last follow up

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC	NCT00697333	Non-small Cell ...	restriction of ...	18 Years -	Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN
Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC	NCT00697333	Non-small Cell ...	restriction of ...	18 Years -	Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN

Spots Global Cancer Trial Database for target volumes